The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profiles-Reference-Cited by-同舟云学术

The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profiles

Published:2021-04 Issue: Volume:238 Page:104134
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

van Alphen Carolien,Cucchi David G.J.,Cloos Jacqueline,Schelfhorst Tim,Henneman Alexander A.,Piersma Sander R.,Pham Thang V.,Knol Jaco C.,Jimenez Connie R.,Janssen Jeroen J.W.M.

Funder

Netherlands Organisation for Scientific Research

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference40 articles.

1. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation;Stone;N. Engl. J. Med.,2017

2. Phase IIB trial of oral midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3;Fischer;J. Clin. Oncol.,2010

3. Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML;Perl;N. Engl. J. Med.,2019

4. New drugs in acute myeloid leukemia;Kadia;Ann. Oncol.,2016

5. A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy;Knapper;Blood.,2006

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications;Mass Spectrometry Reviews;2022-09-26

2. Proteogenomics Analysis Reveals Novel Micropeptides in Primary Human Immune Cells;Immuno;2022-03-23

3. Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors;HemaSphere;2021-06-12